Nyxoah S.A. (NYXH) Stock Price & Growth Analysis

Quote Panel

Updated August 18, 2025

1W -1.79 % 1M -17.25 % 3M -3.24 % 1Y -16.31 %

Key Metrics

Market Cap
245.91M
Shares Outstanding
37.43M
Share in Float
17.07M
Dividende
0

Earning Date
18 Aug 2025
Price Target
6.57
Average Volume
93133
Beta
0.651

Range
5.55-11.87
Industry
Medical - Instruments & Supplies
Website
https://www.nyxoah.com
Sector
Healthcare

Quote Panel

Updated August 18, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

N/A

P/E Ratio

47.28x

P/S Ratio

2.22x

P/B Ratio

0.2

Debt/Equity

-1597.5%

Net Margin

$-2.3

EPS

How NYXH compares to sector?

P/E Ratio

Fundamentals

Relative Strength

NYXH

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

NYXH

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$44M

4044%

2026-Revenue

$2.08

-246%

2026-EPS

$44M

-108%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Buy

Price Target

0.00(N/A)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q2.23

N/A

-0.49
vs -0.21

Q3.23

N/A

-0.29
vs -0.24

Q4.23

N/A

-0.41
vs -0.52

Q1.24

N/A

-0.45
vs -0.49

Q2.24

N/A

-0.46
vs -0.49

Q3.24

N/A

-0.55
vs -0.29

Q4.24

N/A

-0.49
vs -0.41

Q1.25

N/A

-0.63
vs -0.45

Q2.25

N/A

-0.57
vs -0.46

Q3.25

N/A

-0.62
vs -0.55

Sales Growth

YoY

Current

Estimates

Q2.23

+18%

1.1M vs 935K

Q3.23

+436%

976K vs 182K

Q4.23

+40%

1.8M vs 1.3M

Q1.24

+177%

1.2M vs 441K

Q2.24

-30%

771K vs 1.1M

Q3.24

+30%

1.3M vs 976K

Q4.24

-31%

1.3M vs 1.8M

Q1.25

-13%

1.1M vs 1.2M

Q2.25

+73%

1.3M vs 771K

Q3.25

+114%

2.7M vs 1.3M

Return on Equity

QoQ

Q4.22

-11%

-0.11
vs -0.05

Q1.23

-10%

-0.10
vs -0.11

Q2.23

-11%

-0.11
vs -0.10

Q3.23

-7%

-0.07
vs -0.11

Q4.23

-11%

-0.11
vs -0.07

Q1.24

-14%

-0.14
vs -0.11

Q2.24

-11%

-0.11
vs -0.14

Q3.24

-16%

-0.16
vs -0.11

Q4.24

-15%

-0.15
vs -0.16

Q1.25

-24%

-0.24
vs -0.15

Institutionnal Ownership

QoQ

Q4.22

18
vs 18

Q1.23

18
vs 18

Q2.23

16
vs 18

-11%

Q3.23

17
vs 16

Q4.23

16
vs 17

-6%

Q1.24

19
vs 16

19%

Q2.24

20
vs 19

Q3.24

20
vs 20

Q4.24

22
vs 20

10%

Q1.25

26
vs 22

18%

Earnings Growth

YoY

Current

Estimates

Q2.23

N/A

-0.49
vs -0.21

Q3.23

N/A

-0.29
vs -0.24

Q4.23

N/A

-0.41
vs -0.52

Q1.24

N/A

-0.45
vs -0.49

Q2.24

N/A

-0.46
vs -0.49

Q3.24

N/A

-0.55
vs -0.29

Q4.24

N/A

-0.49
vs -0.41

Q1.25

N/A

-0.63
vs -0.45

Q2.25

N/A

-0.57
vs -0.46

Q3.25

N/A

-0.62
vs -0.55

Sales Growth

YoY

Current

Estimates

Q2.23

+18%

1.1M vs 935K

Q3.23

+436%

976K vs 182K

Q4.23

+40%

1.8M vs 1.3M

Q1.24

+177%

1.2M vs 441K

Q2.24

-30%

771K vs 1.1M

Q3.24

+30%

1.3M vs 976K

Q4.24

-31%

1.3M vs 1.8M

Q1.25

-13%

1.1M vs 1.2M

Q2.25

+73%

1.3M vs 771K

Q3.25

+114%

2.7M vs 1.3M

Return on Equity

QoQ

Q4.22

-11%

-0.11
vs -0.05

Q1.23

-10%

-0.10
vs -0.11

Q2.23

-11%

-0.11
vs -0.10

Q3.23

-7%

-0.07
vs -0.11

Q4.23

-11%

-0.11
vs -0.07

Q1.24

-14%

-0.14
vs -0.11

Q2.24

-11%

-0.11
vs -0.14

Q3.24

-16%

-0.16
vs -0.11

Q4.24

-15%

-0.15
vs -0.16

Q1.25

-24%

-0.24
vs -0.15

Institutionnal Ownership

QoQ

Q4.22

18
vs 18

Q1.23

18
vs 18

Q2.23

16
vs 18

-11%

Q3.23

17
vs 16

Q4.23

16
vs 17

-6%

Q1.24

19
vs 16

19%

Q2.24

20
vs 19

Q3.24

20
vs 20

Q4.24

22
vs 20

10%

Q1.25

26
vs 22

18%

Company Description

6.57USD

N/A

47.28x

2.22x

0.2

-1597.5%

$-2.3

$44M

$2.08

$44M

Earnings Growth

Latest News

Latest News

Latest News

Earnings Growth

$44M

$2.08

$44M

Company Description

6.57USD

N/A

47.28x

2.22x

0.2

-1597.5%

$-2.3